US Court Dismisses Viatris EpiPen Suit, But Further Action Possible

Antitrust Suit Dismissed Without Prejudice

US pharmacy KPH Healthcare Services, acting on behalf of purchasing giant McKesson, has seen an antitrust suit filed against Viatris’ Mylan and Pfizer dismissed, although the court said it would allow plaintiffs to come back with a further complaint.

Gavel Law Red Background
Pfizer has just settled antitrust claims over EpiPen • Source: Alamy

More from Legal & IP

More from Generics Bulletin